Comparison of the long-term success rate of smoking cessation among COPD and non-COPD subjects;Comparación del éxito para dejar de fumar a largo plazo en sujetos con EPOC y sin EPOC

Revista del Instituto Nacional de Enfermedades Respiratorias

Volumn 22, Issue 1, 2009, Pages 21-28

  Flores Trujillo, Fernando ^a   Ramírez Venegas, Alejandra ^a   Hernández Zenteno, Rafael J ^a   Méndez Guerra, Mónica ^a   Sansores Martínez, Raúl H ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RELAPSE; SMOKING CESSATION; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE; TREATMENT PLANNING;

EID: 70949092665     PISSN: 01877585     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rabe KF, Hurd S, Anzueto A, et ál; and Global Initiative for Chronic Obstructive Lung Diseases. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-555.
2. Regalado-Pineda J, Lara-Rivas G, Osio-Echánove J, Ramírez-Venegas A. Tratamiento actual del tabaquismo. Salud Pública Mex 2007;49 Supl 2:S270-S279.
3. Xu X, Dockery DW, Ware JH, Speizer FE, Ferris BG Jr. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis 1992;146(5 Pt 1):1345-1348.
4. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002;166:675-679.
5. Willemse B, Lesman-Leegte I, Timens W, Postma D, ten Hacken N. High cessation rates of cigarrete smoking in subjects with and without COPD. Chest 2005;128:3685-3687.
6. Brandt CJ, Ellegaard H, Joensen M, Kallan FV, Sorknaes AD, Tougaard L. Effect of diagnosis of "smoker's lung". RYLUNG Group. Lancet 1997;349:253-254.
7. Pederson LL, Wanklin JM, Lefcoe NM. The effects of counseling on smoking cessation among patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial. Int J Addict 1991;26:107-119.
8. DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol 1991;59:295-304.
9. Sansores RH, Espinosa AM. Manual del programa cognitivo conductual de la clínica para dejar de fumar del INER. México: INER, SSA;1999.
10. Sansores-Martínez RH, Córdoba-Ponce MP, Espinosa-Martínez M, et ál. Evaluación del programa cognitivo-conductual para dejar de fumar del Instituto Nacional de Enfermedades Respiratorias. Rev Inst Nal Enf Resp Mex 1998;11:29-35.
11. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991;86:1119-1127.
12. Miller MR, Hankinson J, Brusasco V, et ál; and ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26:319-338.
13. Celli BR, MacNee W; and ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
14. Górecka D, Bednarek M, Nowiński A, Púscińska E, Goljan-Geremek A, Zieliński J. Effect of treatment for nicotine dependence in patients with COPD. Pneumonol Alergol Pol 2003;71:411-417. (Pubitemid 38168311)
15. Tashkin D, Kanner R, Bailey W, et ál. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomized trial. Lancet 2001;357:1571-1575.
16. Nerín I, Novella P, Crucelaegui A, Beamonte A, Sobradiel N, Gargallo P. Factores predictores de éxito a los 6 meses en fumadores tratados en una unidad de tabaquismo. Arch Bronconeumol 2004;40:558-562. (Pubitemid 40064762)
17. Sherman SE, Lanto AB, Nield M, Yano EM. Smoking cessation care received by veterans with chronic obstructive pulmonary disease. J Rehabil Res Dev 2003;40 (5 Suppl 2):1-12. (Pubitemid 37314970)
18. Ramírez-Venegas A, Sansores RH, Pérez-Padilla R, et ál. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med 2006:173;393-397. (Pubitemid 43228326)
19. Sin DD, Wu L, Anderson JA, et ál. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005;60:992-997.
20. Hanania NA, Darken P, Horstman D, et ál. The efficacy and safety of fluticasone propionate (250 μg)/salmeterol (50 μg) combined in the Diskus inhaler for the treatment of COPD. Chest 2003;124:834-843.
21. Simmons MS, Connett JE, Nides MA, et ál. Smoking reduction and the rate of decline in FEV1: results from the Lung Health Study. Eur Respir J 2005;25:1011-1017.
22. García M, Schiaffino A, Twose J, et ál. Abandono del consumo de tabaco en una cohorte de base poblacional. Arch Bronconeumol 2004:40;348-354.
23. Ramírez-Venegas A, Sansores RH; y Red Nacional de EPOC. Guías para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica. Tercer consenso mexicano para el diagnóstico y el tratamiento de la EPOC. Neumol Cir Torax 2007;66(Supl 2):S5-S76.
24. Jiménez-Ruiz CA, Masa F, Miravitlles M, et ál. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001;119:1365-1370.
25. Tønnesen P, Carrozzi L, Fagerström KO, et ál. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J 2007;29:390-417.
26. Hajek P, Stead LF, West R, Jarvis M. Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev 2005;(1):CD003999.